263 related articles for article (PubMed ID: 9421184)
1. Influence of macrophage-derived apolipoprotein E on plasma lipoprotein distribution of apolipoprotein A-I in apolipoprotein E-deficient mice.
Spangenberg J; Curtiss LK
Biochim Biophys Acta; 1997 Nov; 1349(2):109-21. PubMed ID: 9421184
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
Sontag TJ; Krishack PA; Lukens JR; Bhanvadia CV; Getz GS; Reardon CA
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):262-9. PubMed ID: 24334873
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E gene expression is reduced in apolipoprotein A-I transgenic mice.
Srivastava RA
Mol Cell Biochem; 2000 Jun; 209(1-2):125-9. PubMed ID: 10942210
[TBL] [Abstract][Full Text] [Related]
4. ApoA1 reduces free cholesterol accumulation in atherosclerotic lesions of ApoE-deficient mice transplanted with ApoE-expressing macrophages.
Boisvert WA; Black AS; Curtiss LK
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):525-30. PubMed ID: 10073953
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice.
Zhang W; Yancey PG; Su YR; Babaev VR; Zhang Y; Fazio S; Linton MF
Circulation; 2003 Nov; 108(18):2258-63. PubMed ID: 14581413
[TBL] [Abstract][Full Text] [Related]
6. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
[TBL] [Abstract][Full Text] [Related]
7. Effects of genotype and diet on cholesterol efflux into plasma and lipoproteins of normal, apolipoprotein A-I-, and apolipoprotein E-deficient mice.
Huang Y; Zhu Y; Langer C; Raabe M; Wu S; Wiesenhütter B; Seedorf U; Maeda N; Assmann G; von Eckardstein A
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2010-9. PubMed ID: 9351366
[TBL] [Abstract][Full Text] [Related]
8. Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux.
Lee M; Calabresi L; Chiesa G; Franceschini G; Kovanen PT
Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1475-81. PubMed ID: 12231569
[TBL] [Abstract][Full Text] [Related]
9. Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance.
Liao D; Tan H; Hui R; Li Z; Jiang X; Gaubatz J; Yang F; Durante W; Chan L; Schafer AI; Pownall HJ; Yang X; Wang H
Circ Res; 2006 Sep; 99(6):598-606. PubMed ID: 16931800
[TBL] [Abstract][Full Text] [Related]
10. Protection against atherogenesis in mice mediated by human apolipoprotein A-IV.
Duverger N; Tremp G; Caillaud JM; Emmanuel F; Castro G; Fruchart JC; Steinmetz A; Denèfle P
Science; 1996 Aug; 273(5277):966-8. PubMed ID: 8688083
[TBL] [Abstract][Full Text] [Related]
11. Macrophage apolipoprotein A-I expression protects against atherosclerosis in ApoE-deficient mice and up-regulates ABC transporters.
Su YR; Ishiguro H; Major AS; Dove DE; Zhang W; Hasty AH; Babaev VR; Linton MF; Fazio S
Mol Ther; 2003 Oct; 8(4):576-83. PubMed ID: 14529830
[TBL] [Abstract][Full Text] [Related]
12. Arg123-Tyr166 domain of human ApoA-I is critical for HDL-mediated inhibition of macrophage homing and early atherosclerosis in mice.
Holvoet P; Peeters K; Lund-Katz S; Mertens A; Verhamme P; Quarck R; Stengel D; Lox M; Deridder E; Bernar H; Nickel M; Theilmeier G; Ninio E; Phillips MC
Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):1977-83. PubMed ID: 11742873
[TBL] [Abstract][Full Text] [Related]
13. Retrovirus-mediated expression of apolipoprotein A-I in the macrophage protects against atherosclerosis in vivo.
Ishiguro H; Yoshida H; Major AS; Zhu T; Babaev VR; Linton MF; Fazio S
J Biol Chem; 2001 Sep; 276(39):36742-8. PubMed ID: 11477092
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of PLTP is atherogenic in apolipoprotein E deficient mice.
van Haperen R; van Gent T; van Tol A; de Crom R
Atherosclerosis; 2013 Mar; 227(1):37-42. PubMed ID: 23313246
[TBL] [Abstract][Full Text] [Related]
15. Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice.
Chroni A; Kan HY; Kypreos KE; Gorshkova IN; Shkodrani A; Zannis VI
Biochemistry; 2004 Aug; 43(32):10442-57. PubMed ID: 15301543
[TBL] [Abstract][Full Text] [Related]
16. Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice.
Hewing B; Parathath S; Barrett T; Chung WK; Astudillo YM; Hamada T; Ramkhelawon B; Tallant TC; Yusufishaq MS; Didonato JA; Huang Y; Buffa J; Berisha SZ; Smith JD; Hazen SL; Fisher EA
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):779-89. PubMed ID: 24407029
[TBL] [Abstract][Full Text] [Related]
17. Roles of high apolipoprotein E blood levels and HDL in development of familial dysbetalipoproteinemia in ε2ε2 subjects.
Corsetti JP; Sparks CE; Bakker SJL; Gruppen EG; Dullaart RPF
Clin Biochem; 2018 Feb; 52():67-72. PubMed ID: 29157655
[TBL] [Abstract][Full Text] [Related]
18. Adenoviral vector-mediated overexpression of serum amyloid A in apoA-I-deficient mice.
Webb NR; de Beer MC; van der Westhuyzen DR; Kindy MS; Banka CL; Tsukamoto K; Rader DL; de Beer FC
J Lipid Res; 1997 Aug; 38(8):1583-90. PubMed ID: 9300780
[TBL] [Abstract][Full Text] [Related]
19. Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype.
Frikke-Schmidt R; Nordestgaard BG; Agerholm-Larsen B; Schnohr P; Tybjaerg-Hansen A
J Lipid Res; 2000 Nov; 41(11):1812-22. PubMed ID: 11060351
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E mediates enhanced plasma high-density lipoprotein cholesterol clearance by low-dose streptococcal serum opacity factor via hepatic low-density lipoprotein receptors in vivo.
Rosales C; Tang D; Gillard BK; Courtney HS; Pownall HJ
Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1834-41. PubMed ID: 21597008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
